This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Comparative Real Life Egyptian Experience of the Combination of Sofosbuvir
Plus Daclatasvir or Simeprevir for 12 Weeks in Naïve Cirrhotic Patients
Infected with HCV Genotype 4, Current Drug Safety, May 2023, Bentham Science Publishers,
DOI: 10.2174/1574886317666220510184749.
You can read the full text:
The following have contributed to this page
